{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:16:12Z","timestamp":1788437772596,"version":"build-2803163510"},"reference-count":43,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"8","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>The article does not contain abstract.<\/jats:p>","DOI":"10.5937\/jomb0-60996","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T08:53:06Z","timestamp":1761641586000},"page":"1853-1853","source":"Crossref","is-referenced-by-count":1,"title":["Erratum: Correlation analysis of serum cytokine levels and immune inflammatory factors in cirrhotic portal hypertension (2026, vol. 45, no. 4, pp. 882-888)"],"prefix":"10.5937","volume":"45","author":[{"given":"Yafeng","family":"Yuq","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Shaoxing University (Shaoxing Municipal Hospital), Department of Infectious Diseases (Hepatology), Shaoxing City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiong","family":"Lan","sequence":"additional","affiliation":[{"name":"Jiangsu Provincial People's Hospital, Department of Gastrointestinal Surgery, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Huang","sequence":"additional","affiliation":[{"name":"Jiangsu Provincial People's Hospital, Department of Gastrointestinal Surgery, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqin","family":"Hu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shaoxing University (Shaoxing Municipal Hospital), Department of Geriatrics, Shaoxing City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3964","reference":[{"key":"#cr-split#-ref1.1","doi-asserted-by":"crossref","unstructured":"Kaplan DE, Ripoll C, Thiele M, Fortune BE, Simonetto DA, Garcia-Tsao G, Bosch J. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 2024 May 1","DOI":"10.1097\/HEP.0000000000000647"},{"key":"#cr-split#-ref1.2","unstructured":"79(5): 1180-211. doi: 10.1097\/H EP 00000000 00000647. Epub 2023 Oct 23. PMID: 37870298;"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Turco L, Reiberger T, Vitale G, La Mura V Carvedilol as the new nonselective beta-blocker of choice in patients with cirrhosis and portal hypertension. Liver Int 2023 Jun; 43(6): 1183-94. doi: 10.1111\/liv.15559. Epub 2023 Apr 17. PMID: 36897563;","DOI":"10.1111\/liv.15559"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Wu L, Yang L, Qian X , Hu W, Wang S, Yan J. Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment. J Funct Biomater 2024 Aug 16; 15(8): 229. doi: 10.3390\/ jfb15080229. PMID: 39194667; PMCID: PMC11355305;","DOI":"10.3390\/jfb15080229"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Tonon M, Piano S. Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences. Med Clin North Am 2023 May; 107(3): 505-16. doi: 10.1016\/j.m cna.2022.12.004. Epub 2023 Feb 20. P M ID :37001950;","DOI":"10.1016\/j.mcna.2022.12.004"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Jothimani D, Rela M, Kamath PS. Liver Cirrhosis and Portal Hypertension: How to Deal with Esophageal Varices? Med Clin North Am 2023 May; 107(3): 491-504. doi: 10.1016\/j.m cna.2023.01.002. Epub 2023 Feb 20. PMID: 37001949;","DOI":"10.1016\/j.mcna.2023.01.002"},{"key":"#cr-split#-ref6.1","doi-asserted-by":"crossref","unstructured":"Sharpton SR, Loomba R. Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC. Hepatology 2023 Dec 1","DOI":"10.1097\/HEP.0000000000000848"},{"key":"#cr-split#-ref6.2","unstructured":"78(6): 1896-906. doi: 10.1097\/H EP0000000000000278. Epub 2023 Jan 3. PMID: 37013380;"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Reiberger T. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Hepatol Commun 2022 May; 6(5): 950-64. doi: 10.1002\/hep4.1855. Epub 2021 Dec 14. PMID: 34904404; PMCID: PMC9035575;","DOI":"10.1002\/hep4.1855"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Kristensen H, Kimer N, M0ller S. Indications and methods for measuring portal hypertension in cirrhosis. Scand J Gastroenterol 2022 Oct; 57(10): 1149-57. doi: 10.1080\/00365521.2022.2065889. Epub 2022 May 6. PMID: 35514215;","DOI":"10.1080\/00365521.2022.2065889"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Terbah R, Testro A, Gow P Majumdar A, Sinclair M. Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic Opportunities. Nutrients 2023 Dec 21; 16(1): 35. doi: 10.339 0\/n u16010035. PMID: 38201864; PMCID: PMC10780673;","DOI":"10.3390\/nu16010035"},{"key":"#cr-split#-ref10.1","unstructured":"Li X , Kang N, Qi X, Huang Y Artificial intelligence in the diagnosis of cirrhosis and portal hypertension. J Med Ultrason (2001) 2022 Jul"},{"key":"#cr-split#-ref10.2","unstructured":"49(3): 371-9. doi: 10.1007\/ s10396-021-01153-8. Epub 2021 Nov 17. PMID: 34787742;"},{"key":"ref11","unstructured":"Brown RS Jr, Brown KA, Flamm S, Bejarano RE, Rahimi RS, Singal AK, Rockey DC. Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives. Hepatol Commun 2025 Apr 3; 9(4): e0682. doi: 10 .1 09 7\/H C 9.00 00000000000682. PMID: 40178492; PMCID: PMC11970884;"},{"key":"#cr-split#-ref12.1","doi-asserted-by":"crossref","unstructured":"Alvarado-Tapias E, Brujats A, Puente A, Ardevol A, Rodriguez-Arias A, Fajardo J, Pavel O, Garcia-Guix M, Aracil C, Poca M, Cuy\u00e0s B, Canto E, Montan\u00e9s R, Garcia-Osuna A, Escorsell \u00c0, Torras X , Villanueva C. Hemodynamic effects of carvedilol plus simvastatin in cir-rhosis with severe portal hypertension and suboptimal response to -blockers: A double-blind, placebo-con-trolled, randomised trial. Hepatology 2025 Jul 1","DOI":"10.1097\/HEP.0000000000001148"},{"key":"#cr-split#-ref12.2","unstructured":"82(1): 140-54. doi: 1 0 .10 97\/H EP 0000 0000 0000 1148. Epub 2024 Nov 7. PMID: 39509369;"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y Liu J, Luo R, Wu D, Xu P Wu D, Li X. Comprehensive evaluation of the efficacy and safety of LPV\/r drugs in the treatment of SARS and MERS to pro-vide potential treatment options for COVID-19. Aging (Albany NY) 2021 Apr 20; 13(8): 10833-52. doi: 10.18632\/aging.202860. Epub 2021 Apr 20. PMID: 33879634; PMCID: PMC8109137;","DOI":"10.18632\/aging.202860"},{"key":"ref14","unstructured":"Hasan I. Cirrhosis Management: Utilisation and Opti-mising Non-Invasive Tests in Portal Hypertension. Acta Med Indones 2024 Jul; 56(3): 273-5. PMID: 39463106;"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bailly C, Xiang C, Zhang JH. Traditional uses and phyto-chemical constituents of Cynanchum otophyllum C. K. Schneid (Qingyangshen). World J Tradit Chin Med 2023; 9: 1-7. doi: 10.4103\/2311-8571.353189;","DOI":"10.4103\/2311-8571.353189"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Guo Y Ma X , Nie Y, Kostallari E, Gao J. Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension. Front Immunol 2023 Mar 9; 14: 1174562. doi: 10.3389\/fim m u.2023.1174562. PMID: 36969230; PMCID: PMC10034766;","DOI":"10.3389\/fimmu.2023.1174562"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Wu D, Xu P Ruan X , Yan J, Liu J, Li X. Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines 2022 Sep 10; 10(9): 2248. doi: 10.3390\/ biomedicines10092248. PMID: 36140350; PMCID: PMC9496572;","DOI":"10.3390\/biomedicines10092248"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Shukla A, Rockey DC, Kamath PS, Kleiner DE, Singh A, Vaidya A, Koshy A, Goel A, D\u00f4kmeci AK, Meena B, Philips CA, Sharma CB, Payawal DA, Kim DJ, Lo GH, Han G, Qureshi H, Wanless IR, Jia J, Sollano JD, Al Mahtab M, Muthiah MD, Sonderup MW, Nahum MS, Merican MIB, Ormeci N, Kawada N, Reddy R, Dhiman RK, Gani R, Hameed SS, Harindranath S, Jafri W, Qi X, Chawla Y K , Furuichi Y, Zheng m H, Sarin SK. Noncirrhotic portal fibrosis\/idiopathic portal hyperten-sion: APASL recommendations for diagnosis and man-agement. Hepatol Int 2024 Dec; 18(6): 1684-711. doi: 10.1007\/s12072-024-10739-6. Epub 2024 Nov 15. PMID: 39546143;","DOI":"10.1007\/s12072-024-10739-6"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Tee DW, Wong HF Effective common Chinese herbal medicines used in treating chronic cholecystitis with liver-gallbladder dampness-heat syndrome: A review of clini-cal studies in the past 10 years. World J Tradit Chin Med 2023; 9: 8-20. doi: 10.4103\/2311-8571.364414;","DOI":"10.4103\/2311-8571.364414"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Yu X , Wu D, Xu P Lv L, Ruan X , Liu Q, Feng Y, Liu J, Li X. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adeno-carcinoma by multiple omics research. Anticancer Drugs 2022 Oct 1; 33(9): 943-59. doi: 10.1097\/CAD. 00 00000000001319. Epub 2022 Aug 9. PMID: 35946526; PMCID: PMC9481295;","DOI":"10.1097\/CAD.0000000000001319"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Wu L, Liu Q, Ruan X , Luan X , Zhong Y Liu J, Yan J, Li X. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD). Biomedi-cines 2023 Jun 29; 11(7): 1861. doi: 10.3390\/bio-medicines11071861. PMID: 37509501; PMCID: PMC10377220;","DOI":"10.3390\/biomedicines11071861"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Gillespie SL, Hanrahan TP Rockey DC, Majumdar A, Hayes PC. Review article: controversies surrounding the use of carvedilol and other beta blockers in the manage-ment of portal hypertension and cirrhosis. Aliment Phar-macol Ther 2023 Mar; 57(5): 454-63. doi: 10.1111\/ apt.17380. Epub 2023 Jan 24. PMID: 36691947;","DOI":"10.1111\/apt.17380"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Villanueva C, Tripathi D. Carvedilol, probably the -block-er of choice for everyone with cirrhosis and portal hyper-ten-sion: However, not so fast! Liver Int 2023 Jun; 43(6): 1154-6. doi: 10.1111\/liv.15582. PMID: 37166136;","DOI":"10.1111\/liv.15582"},{"key":"ref24","unstructured":"Celsa C, Veneziano M, Di Giorgio FM, Cannova S, Lombardo A, Errigo E, Landro G, Simone F Sinagra E, Calvaruso V. Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBVand HCV-Related Cirrhosis: A Comprehensive Review. Medicina (Kaunas) 2024 Apr 24; 6 0 (5 ): 690. doi: 1 0 .3 3 9 0 \/ m edicina60050690. PMID: 3 8 7 9 2 8 7 3 ; PM CID: PMC11123262;"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y, Ruan X , Wu D, Xu P , Liu J, Wu D, Li X. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcino-ma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs 2022 Jan 1; 33(1): e590-e603. doi: 10.1097\/CAD.0000000000001189. PMID: 34338240; PMCID: PMC8670349;","DOI":"10.1097\/CAD.0000000000001189"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Wu L, Li X , Qian X , Wang S, Liu J, Yan J. Lipid Nano-particle (LNP) Delivery Carrier-Assisted Targeted Con-trolled Release mRNA Vaccines in Tumor Immunity. Vaccines (Basel) 2024 Feb 12; 12(2): 186. doi: 10.3390\/vaccines12020186. PMID: 38400169; PMCID: PMC10891594;","DOI":"10.3390\/vaccines12020186"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Chang G, Sun J, Li J, Li T. Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic Review and Meta-Analysis. Clin Res Hepatol Gastroenterol 2024 Jun; 48(6): 102361. doi: 1 0 .1 0 1 6\/j.clinre.2024. 102361. Epub 2024 May 1. PMID: 38701917;","DOI":"10.1016\/j.clinre.2024.102361"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Albillos A, Banares R, Hernandez-Gea V; en repre-sentacion del grupo espanol de Consenso en Hipertension Portal. Portal hypertension: recommendations for diagnosis and treatment. Consensus document spon-sored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Centre for Liver and Digestive Diseases (CIBERehd). Gastroenterol Hepatol 2025 Jan; 48(1): 502208. English, Spanish. doi: 10.1016\/j.gastrohep.2024. 502208. Epub 2024 Sep 30. PMID: 39756832;","DOI":"10.1016\/j.gastre.2024.502208"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Lan T, Li S, Yu H, Kostallari E, Gao J. Editorial: Com - munity series in hepatic immune response underlying liver cirrhosis and portal hypertension, volume II. Front Immunol 2023 Oct 11; 14: 1305666. doi: 10.3389\/ fimmu.2023.1305666. PMID: 37901235; PMCID: PMC10600445;","DOI":"10.3389\/fimmu.2023.1305666"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Wu L, Chen X , Zeng Q, Lai Z, Fan Z , Ruan X , Li X , Yan J. NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by O CLR algorithm and immune score. Heliyon 2024 Mar 28; 10(7): e28282. doi: 10.1016\/j.heliyon.2024.e28282. PMID: 38601554; PMCID: PM C11004709;","DOI":"10.1016\/j.heliyon.2024.e28282"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Ibrahim RS, El-Mezayen NS, El-Banna AA. Alleviation of liver cirrhosis and associated portal-hypertension by Astragalus species in relation to their UPLC-MS\/MS metabolic profiles: a mechanistic study. Sci Rep 2022 Jul 13; 12(1): 11884. doi: 10.1038\/s41598-022-15958-1. PMID: 35831335; PMCID: PMC9279505;","DOI":"10.1038\/s41598-022-15958-1"},{"key":"#cr-split#-ref32.1","doi-asserted-by":"crossref","unstructured":"Vairappan B, Wright G, M S, Ravikumar TS. Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF Eur J Pharmacol 2023 Nov 5","DOI":"10.1016\/j.ejphar.2023.176010"},{"key":"#cr-split#-ref32.2","unstructured":"958: 176010. doi: 10.1016\/j.ejphar. 2023.176010. Epub 2023 Aug 25. PMID: 37634841;"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Wu L, Li H, Liu Y, Fan Z, Xu J, Li N, Qian X , Lin Z, Li X, Yan J. Research progress of 3D-bioprinted functional pancreas and in vitro tumor models. International Journal of Bioprinting 2024, 10(1), 1256. doi: 10.36922\/ ijb.1256;","DOI":"10.36922\/ijb.1256"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Tapper EB, Ospina E, Salim N, Chen X , Nikirk S. Lactu-lose therapy for patients with cirrhosis, portal hyperten-sion, and poor patient-reported outcomes: The Mi-Kristal trial. Hepatology 2023 Oct 1; 78(4): 1159-67. doi: 10.1097\/HER0000000000000408. Epub 2023 Apr 18. PMID: 37066820; PMCID: PMC10524505;","DOI":"10.1097\/HEP.0000000000000408"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Wu L, Li X , Yan J. Commentary: Machine learning devel-oped an intratumor heterogeneity signature for predict-ing prognosis and immunotherapy benefits in cholangio-carcinoma. Transl Oncol 2024 Jul; 45: 101995. doi: 10.1016\/j.tranon.2024.101995. Epub 2024 May 9. P M ID :38789241;","DOI":"10.1016\/j.tranon.2024.101995"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Kotani K, Enomoto M, Uchida-Kobayashi S, Tamori A, Yukawa-Muto Y, Odagiri N, Motoyama H, Kozuka R, Kawamura E, Hagihara A, Fujii H, Kageyama K, Yamamoto A, Yoshida A, Higashiyama S, Kawabe J, Kawada N. Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir\/velpatasvir for decompensated hepatitis C-related cirrhosis. J Gastro-enterol 2023 Apr; 58(4): 394-404. doi: 10.1007\/ s00535-023-01963-2. Epub 2023 Feb 2. PMID: 36729172; PMCID: PMC10049944;","DOI":"10.1007\/s00535-023-01963-2"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Bao YF, Zhang ZH, Yu HY, Huo XN , Lu Y, Xu TC. Development of intelligent acupuncture applications and related technologies. World J Tradit Chin Med 2023; 9: 2-8. doi: 10.4103\/2311-8571.364416;","DOI":"10.4103\/2311-8571.364416"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Zhu CP, Liu SQ, Wang KQ, Xiong HL, Aristu-Zabalza P , Boyer-Diaz Z, Feng JF, Song SH, Luo C, Chen WS, Zhang X , Dong WH, Gracia-Sancho J, Xie WF Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension. Gastroenterology 2024 Oct; 167(5): 993-1007. doi: 10.1053\/j.gastro.2024. 06.007. Epub 2024 Jun 19. PMID: 38906512;","DOI":"10.1053\/j.gastro.2024.06.007"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Eratum: Korelaciona analiza serumskih nivoa citokina i imunoinflamatornih faktora kod portalne hipertenzije u sklopu ciroze jetre (2026, vol. 45, br. 4, str. 882-888)"],"language":"en","link":[{"URL":"https:\/\/aseestant.ceon.rs\/index.php\/jomb\/article\/download\/60996\/29186","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2026\/1452-82582608853Y.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:39:32Z","timestamp":1788435572000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582608853Y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-60996","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}